Capital Ideas
ResearchGet Premium

ACCESS THE LATEST RESEARCH AND INSIGHTS

MEDEXUS CEO INTERVIEW: GROWING FAST, EBITDA POSITIVE, $27 MILLION CASH

Watch our video interview with Ken d’Entremont, CEO of Medexus Pharmaceuticals, to find out what you may be missing with this fast growing company.

MEDEXUS CEO INTERVIEW: GROWING FAST, EBITDA POSITIVE, $27 MILLION CASH

Watch our video interview with Ken d’Entremont, CEO of Medexus Pharmaceuticals, to find out what you may be missing with this fast growing company.


“The Best Retail Stock to Buy Today”

Also inside: New Research on a Cash-Rich Pharma That Has 65% Upside.

“The Best Retail Stock to Buy Today”

Also inside: New Research on a Cash-Rich Pharma That Has 65% Upside.


CELEBRITY FACTOR DRIVING THIS RETAIL STOCK

What’s the best retail stock to buy? We’ve got it in today’s new Digest, which we’ll publish at 7 pm eastern time, accompanied by the usual email alert.

CELEBRITY FACTOR DRIVING THIS RETAIL STOCK

What’s the best retail stock to buy? We’ve got it in today’s new Digest, which we’ll publish at 7 pm eastern time, accompanied by the usual email alert.


MEDEXUS PHARMACEUTICALS CEO INTERVIEW THIS WEEK

We’ll post our interview this week with Ken d’Entremont, CEO of Medexus Pharmaceuticals, a specialty pharma company with strong growth and $27 million in cash.

MEDEXUS PHARMACEUTICALS CEO INTERVIEW THIS WEEK

We’ll post our interview this week with Ken d’Entremont, CEO of Medexus Pharmaceuticals, a specialty pharma company with strong growth and $27 million in cash.


MICROSOFT GETS TARGET BOOST AS IT BEATS FAANGs

MICROSOFT GETS TARGET BOOST AS IT BEATS FAANGs


BREXIT DEAL, NETFLIX EARNINGS & CRONOS SURGES

BREXIT DEAL, NETFLIX EARNINGS & CRONOS SURGES


NINE TOP PICKS & MY DEEP DIVE ON ARITZIA ;-)

Access the new Digest to find out how an equities research team has grown its small cap portfolio by 80%+ the last three years.

NINE TOP PICKS & MY DEEP DIVE ON ARITZIA ;-)

Access the new Digest to find out how an equities research team has grown its small cap portfolio by 80%+ the last three years.


Up 28% This Year, Nine Top Picks from Outperforming Portfolio

Let the Pros Do the Work. Nine Top Picks from Portfolio Up 82% Since Inception.

Up 28% This Year, Nine Top Picks from Outperforming Portfolio

Let the Pros Do the Work. Nine Top Picks from Portfolio Up 82% Since Inception.



Error X
Your e-mails don't match.
Close